PLSE (STOCKS)
Pulse Biosciences, Inc Common Stock (DE)
$23.600000
-1.650000 (-6.53%)
Prev close: $25.250000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Medical Specialties
- CEO
- Paul A. LaViolette
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $1,585.08M
- Employees
- 75
- P/E (TTM)
- -22.24
- P/B (TTM)
- 18.45
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Analyst Recommendations
3
Strong Buy
4
Buy
1
Hold
0
Sell
Recent News
No recent news found for this ticker.
Earnings Surprises
| Period | Actual | Estimate | Surprise | Surprise % |
|---|---|---|---|---|
|
Sep 2025 (Q3)
|
$-0.29 | $-0.32 | +0.0262 | +8.29% |
|
Jun 2025 (Q2)
|
$-0.20 | $-0.27 | +0.0652 | +24.59% |
|
Mar 2025 (Q1)
|
$-0.17 | $0.00 | +0.0000 | +0.00% |
|
Dec 2024 (Q4)
|
$-0.17 | $0.00 | +0.0000 | +0.00% |
Financial Statements
| Revenues | $86.00K |
| Costs And Expenses | $79.03M |
| Nonoperating Income/Loss | $4.21M |
| Research and Development | $44.46M |
| Operating Income/Loss | -$78.95M |
| Income/Loss From Continuing Operations After Tax | -$74.73M |
| Income/Loss From Continuing Operations Before Tax | -$78.07M |
| Net Income/Loss | -$74.73M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | -$74.73M |
| Net Income/Loss Available To Common Stockholders, Basic | -$74.73M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | -$1.14 |
| Basic Average Shares | 203,016,000 |
| Assets | $108.77M |
| Current Assets | $97.16M |
| Inventory | $57.00K |
| Other Current Assets | $97.10M |
| Noncurrent Assets | $11.61M |
| Fixed Assets | $1.06M |
| Other Non-current Assets | $10.55M |
| Liabilities | $16.07M |
| Current Liabilities | $9.70M |
| Accounts Payable | $2.98M |
| Wages | $3.59M |
| Other Current Liabilities | $3.13M |
| Noncurrent Liabilities | $6.37M |
| Equity | $92.69M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $92.69M |
| Liabilities And Equity | $108.77M |
| Net Cash Flow From Operating Activities | -$48.51M |
| Net Cash Flow From Operating Activities, Continuing | -$48.51M |
| Net Cash Flow From Investing Activities | -$283.00K |
| Net Cash Flow From Investing Activities, Continuing | -$283.00K |
| Net Cash Flow From Financing Activities | $64.98M |
| Net Cash Flow From Financing Activities, Continuing | $64.98M |
| Net Cash Flow | $16.18M |
| Net Cash Flow, Continuing | $16.18M |
| Comprehensive Income/Loss | -$74.73M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | -$74.73M |
| Other Comprehensive Income/Loss | -$74.73M |